Using digital technology to improve treatment for opioid use disorder
Digital Device ID Targeting for Increasing Medications for Opioid Use Disorder: A Feasibility and Acceptability Study
This study is exploring a new way to help people with opioid use disorder by using technology to better connect with them and support their treatment, all aimed at reducing the risks of overdose and other related issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10666435 on NIH RePORTER |
What this research studies
This research investigates a new method to enhance the identification and ongoing treatment of individuals with opioid use disorder (OUD) by utilizing device ID targeting technology. This approach leverages anonymized data to engage patients more effectively, aiming to reduce risks associated with drug overdose, comorbid substance use, and impaired driving. By applying techniques similar to those used by leading tech companies, the study seeks to improve outreach and intervention strategies for those at risk of OUD. The research will assess the feasibility and acceptability of this method in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who may benefit from enhanced treatment engagement and support.
Not a fit: Patients who do not have opioid use disorder or those who are not seeking treatment for substance use issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective identification and treatment strategies for patients with opioid use disorder, ultimately reducing overdose rates and improving overall health outcomes.
How similar studies have performed: Similar approaches have shown initial success in other health contexts, particularly during the COVID-19 pandemic, indicating potential for effectiveness in addressing opioid use disorder.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Young, Sean — University of California-Irvine
- Study coordinator: Young, Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.